Primrose Bio attended the BIO International Convention, June 22-25 in San Diego. It was a valuable opportunity to connect with partners and innovators across mRNA, conjugate vaccines, and protein expression, and to explore how Primrose can support next-generation vaccine and biologics development.
Our technologies are already used in marketed products by several of the world’s leading pharmaceutical companies, including Merck, Jazz Pharmaceuticals, Alvogen, and Serum Institute of India.
Louis J. Cantolupo, Jennifer Wittbold, and Alec Tzianabos represented Primrose Bio at the event.
